Skip to main content
Clinical Trials/NCT01170273
NCT01170273CompletedPhase 3

Vitamin D in Vulnerable Adults

VA Office of Research and Development1 site in 1 country130 target enrollmentStarted: August 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
130
Locations
1
Primary Endpoint
Change in Short Physical Performance Battery Test Score

Study Overview

Brief Summary

Vitamin D insufficiency is a problem of growing concern, given its prevalence in older persons and the association of low vitamin D with multiple major health problems, including mobility and balance deterioration and falls, cardiovascular disease, diabetes, and certain cancers. Sedentary persons are particularly vulnerable for these health problems and generally not adherent to prescribed physical activity. This study will investigate if treatment with vitamin D will benefit physical performance in male veterans age 65 to 95.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
65 Years to 95 Years (Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •male veterans
  • •65 to 95 years of age
  • •independent
  • •sedentary
  • •vitamin D insufficiency

Exclusion Criteria

  • •hypercalcemia
  • •renal failure
  • •living in a nursing home

Arms & Interventions

Placebo Arm

Placebo Comparator

placebo capsule

Intervention: placebo (Dietary Supplement)

Cholecalciferol 4000 IU

Experimental

cholecalciferol 4000 IU daily

Intervention: vitamin D (Dietary Supplement)

Outcomes

Primary Outcomes

Change in Short Physical Performance Battery Test Score

Time Frame: baseline and 9 months

The short physical performance battery (SPPB) examines 3 areas of lower extremity function: static balance test, gait speed test and getting in and out of a chair test. The total SPPB score is the sum of the scores of the 3 components and can range from 0 to 12, with 0 reflecting severe limitations and 12 minimal or no limitations. The ranges for each subscale are: balance (0-4), gait speed (0-4), sit-to-stand (0-4). In all the subscales, 0 reflects worse outcome and 4 best outcome.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Fed
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Vitamin D in Vulnerable Adults (VIVA-VA) | Clinical Trial